Picture of Gain Therapeutics logo

GANX — Gain Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Brief: Gain Therapeutics Reports Full Year 2022 Financial Results And Business Update

March 23 (Reuters) - Gain Therapeutics Inc  GANX.O :
    * GAIN THERAPEUTICS REPORTS FULL YEAR 2022 FINANCIAL RESULTS
AND
BUSINESS UPDATE
    * GAIN THERAPEUTICS INC - $22.1 MILLION IN CASH AND CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF DECEMBER 31, 2022
    * GAIN THERAPEUTICS INC - COMPANY EXPECTS COMPLETION OF
IND-ENABLING STUDIES OF GT-02287 IN H1 2023
    * GAIN THERAPEUTICS INC - SUBMISSION OF DOSSIER TO START
PHASE 1
CLINICAL TRIAL OF GT-02287 IN GBA1 PARKINSON'S DISEASE EXPECTED
BY MID-YEAR 2023

Source text for Eikon:  ID:nGNX8VSz9n 
Further company coverage:  GANX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Gain Therapeutics

See all news